Company Filing History:
2 out of 998 
1 out of 987 
1 out of 2,082 
Years Active: 2023-2025
Title: Leandro Moretti: Innovator in Fibronectin-Integrin Interaction and TGF-beta Modulation
Introduction
Leandro Moretti is a notable inventor based in Charlottesville, VA (US). He has made significant contributions to the field of biomedical research, particularly in the areas of fibronectin-integrin interactions and transforming growth factor-beta (TGF-beta) modulation. With a total of 2 patents, Moretti's work has the potential to impact various therapeutic approaches.
Latest Patents
Moretti's latest patents include innovative compositions and methods for detecting and regulating fibronectin-integrin interaction and signaling. These patents provide antibodies that consist of specific amino acid sequences, as well as scFv peptides that can detect and target conformational states of fibronectin in samples. Additionally, his work outlines methods for treating diseases associated with abnormal expression of fibronectin and screening for compounds that selectively bind to these conformational states. Another significant patent focuses on LEMD3, which antagonizes TGF-beta-driven Smad2/3 transcription in a stiffness-dependent manner. This patent describes methods for modulating TGF-beta biological activity in vertebrate subjects, offering new avenues for therapeutic intervention.
Career Highlights
Throughout his career, Leandro Moretti has worked with prestigious institutions such as the University of Virginia and Emory University. His research has garnered attention for its innovative approaches to complex biological interactions and potential clinical applications.
Collaborations
Moretti has collaborated with notable colleagues, including Thomas Harrison Barker and Dwight M Chambers. These partnerships have contributed to the advancement of his research and the development of his patented technologies.
Conclusion
Leandro Moretti's contributions to the fields of fibronectin-integrin interaction and TGF-beta modulation highlight his role as an influential inventor. His patents reflect a commitment to advancing biomedical research and developing innovative solutions for complex health challenges.